Answer
No. It is immunotherapy made from two monoclonal antibodies that block the PD-1 and LAG-3 immune checkpoints.
Sources for this answer
- Opdualag 240 mg/80 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.